Anti-HIV T cell therapy: Filed IND for a Phase I/II trial

By WIR Staff | Jun 20, 1994 | 7:00 AM GMT

Cell Genesys Inc. (CEGE), Foster City, Calif.
Product: Anti-HIV T cell

Read the full 112 word article

How to gain access

Continue reading with a
two-week free trial.